Health
In Pancreatic Cancer, New Biomarker May Predict Benefit of Tumor-Penetrating Peptide – Genetic Engineering & Biotechnology News
Study of pancreatic cancer identified biomarker that may indicate which patients would respond best to combination therapies incorporating a tumor-penetrating peptide….
Hunkered behind a dense layer of fibrotic tissue, pancreatic tumors stubbornly resist the delivery of therapeutic molecules. Yet this barrier, this desmoplastic tumor tissue, can be penetrated by iRGD, a nine-amino-acid cyclic peptide. In experiments with models of pancreatic cancer, specifically, mouse models and organoids, iRGD was found to penetrate tumors via a molecular pathway mediated by 5 integrin, a protein that is produced by carcinoma-associated fibroblasts (CAFs). This newfound role…
-
General18 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
General24 hours agoThe best ways to clean your home coffee machine
-
Noosa News17 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba